← Eichor
Study identifier: NCT07297394 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mechanisms of Maternal Immune Tolerance in Early Pregnancy

Condition: Pregnancy · Immune Tolerance · In Vitro Fertilization  ·  Sponsor: University Hospital, Basel, Switzerland

PhaseN/A
Planned participants100
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study explores the mechanisms of maternal immune tolerance in early pregnancy by characterizing immune cell profiles and functional pathways during the first trimester. The goal is to identify immunological factors that support healthy gestation and prevent complications such as miscarriages.

This description comes directly from the study's public registry record.

Talk to the study team

Ursula Gobrecht-Keller, MD  ·  +41 61 265 93 37  ·  ursula.gobrecht@usb.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital BaselBasel, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07297394